Heron Therapeutics Inc’s recently made public that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17 ’23. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.14 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Forbes William P bought 50,000 shares, generating $46,995 in total proceeds. Upon buying the shares at $0.94, the EVP, Chief Development Officer now owns 54,000 shares.
Before that, Collard Craig A bought 150,000 shares. Heron Therapeutics Inc shares valued at $137,970 were divested by the Chief Executive Officer at a price of $0.92 per share. As a result of the transaction, Collard Craig A now holds 186,496 shares, worth roughly $0.33 million.
Rodman & Renshaw initiated its Heron Therapeutics Inc [HRTX] rating to a Buy in a research note published on June 13, 2024; the price target was $7. A number of analysts have revised their coverage, including CapitalOne’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Needham also remained covering HRTX and reiterated its “Buy” recommendation on March 13, 2024. Guggenheim started covering the stock on May 27, 2020. It rated HRTX as “a Buy”.
Price Performance Review of HRTX
On Tuesday, Heron Therapeutics Inc [NASDAQ:HRTX] saw its stock fall -1.66% to $1.78. Over the last five days, the stock has lost -1.11%. Heron Therapeutics Inc shares have risen nearly 4.71% since the year began. Nevertheless, the stocks have risen 191.90% over the past one year. While a 52-week high of $3.93 was reached on 06/12/24, a 52-week low of $0.50 was recorded on 10/11/24. SMA at 50 days reached $1.9066, while 200 days put it at $2.6142.
Levels Of Support And Resistance For HRTX Stock
The 24-hour chart illustrates a support level at 1.7167, which if violated will result in even more drops to 1.6533. On the upside, there is a resistance level at 1.8267. A further resistance level may holdings at 1.8733. The Relative Strength Index (RSI) on the 14-day chart is 40.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0895, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.39%. Stochastics %K at 49.07% indicates the stock is a holding.
How much short interest is there in Heron Therapeutics Inc?
A steep rise in short interest was recorded in Heron Therapeutics Inc stocks on 2024-09-30, dropping by -4.21 million shares to a total of 31.7 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 35.92 million shares. There was a decline of -13.3%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 20, 2020 when Needham resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $48.
